Related Experiment Videos
Antithrombotic controversies in off-pump coronary bypass
Hratch Karmanoukian1, Bashir Attuwabi, Nader D Nader
1Department of Surgery and Anesthesiology, State University of New York at Buffalo, Buffalo, NY 14215, USA. drk@diagnosisheart.com
Seminars in Thoracic and Cardiovascular Surgery
|August 18, 2005
Summary
This review evaluates perioperative antithrombotics in coronary revascularization surgery. It examines anticoagulation strategies, bleeding risks, and the inflammatory response, highlighting knowledge gaps for improved patient outcomes.
Area of Science:
- Cardiovascular Surgery
- Hematology
- Anesthesiology
Background:
- Perioperative antithrombotic use in coronary revascularization lacks standardized protocols.
- Understanding coagulation and inflammatory responses is crucial for managing cardiac surgery patients.
Purpose of the Study:
- To evaluate perioperative antithrombotic strategies in coronary revascularization.
- To analyze the role of anticoagulation in off-pump coronary revascularization (OPCAB).
- To explore the interplay between coagulation, inflammation, and adverse perioperative events.
Main Methods:
- Literature review of coagulation pathophysiology in cardiac surgery.
- Analysis of prophylactic antithrombosis and bleeding complications.
- Examination of heparinization and its reversal in coronary surgery.
- Review of inflammatory response evidence and therapeutic strategies.
Main Results:
- Anticoagulation practices for OPCAB vary significantly between institutions.
- Prophylactic antithrombotics play a role in both preventing thrombosis and causing bleeding complications.
- The inflammatory response is linked to perioperative organ dysfunction.
Conclusions:
- Further research is needed to optimize anticoagulant use in cardiac surgery.
- Standardization of anticoagulation protocols may improve patient safety.
- Managing the inflammatory response is a potential therapeutic target.